|
Real-time Estimate
Cboe BZX
09:26:42 28/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 815.10 USD | -0.12% |
|
+1.64% | +6.09% |
| 06:42pm | Evercore ISI Adjusts Price Target on Regeneron Pharmaceuticals to $850 From $900 | MT |
| 04:58pm | Canaccord Genuity Adjusts Price Target on Regeneron Pharmaceuticals to $922 From $875 | MT |
| Market Cap | 8.15TCr 7.31TCr 6.75TCr 6.12TCr 11TCr 7,74100Cr 12TCr 81TCr 32TCr 4,05700Cr 31TCr 30TCr 12,86600Cr | P/E 2026 * |
17.1x | P/E 2027 * | 15.8x |
|---|---|---|---|---|---|
| Enterprise Value | 7.39TCr 6.63TCr 6.12TCr 5.55TCr 10TCr 7,01800Cr 11TCr 73TCr 29TCr 3,67900Cr 28TCr 27TCr 11,66600Cr | EV / Sales 2026 * |
4.2x | EV / Sales 2027 * | 3.79x |
| Free-Float |
71.06% | Yield 2026 * |
0.48% | Yield 2027 * | 0.53% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| REGN | Delayed | |
CBOE
| REGN | Real-time | |
|
Mexican S.E.
| REGN * | End-of-day quote | |
|
Tradegate
| RGO | Real-time | |
|
Xetra
| RGO | End-of-day quote | |
|
London S.E.
| 0R2M | Delayed | |
|
Boerse Muenchen
| RGO | Real-time | |
|
Borsa Italiana
| 1REGN | End-of-day quote | |
|
Deutsche Boerse AG
| RGO | Delayed | |
|
Wiener Boerse
| REGN | End-of-day quote | |
|
Börse Stuttgart
| RGO | Delayed | |
|
Lima
| REGNUS | End-of-day quote |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 week | +1.64% | ||
| Current month | +7.99% | ||
| 1 month | +8.86% | ||
| 3 months | +17.79% | ||
| 6 months | +11.90% | ||
| Current year | +6.09% |
| 1 week | 796.61 |  | 825.52 |
| 1 month | 722.02 | | 825.52 |
| Current year | 591.52 | | 859.34 |
| 1 year | 591.52 | | 859.34 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 01/01/2001 | |
| Chief Executive Officer | 73 | 08/01/1988 | |
| Director of Finance/CFO | 55 | 05/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 09/06/2023 | |
Joseph Goldstein
BRD | Director/Board Member | 85 | 01/06/1991 |
George Sing
BRD | Director/Board Member | 76 | 08/01/1988 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/10/26 | Sell | Chief Technology Officer | -4,147 | 0.0041% | ||
| 03/09/26 | Sell | Executive/Senior Manager | -1,131 | 0.0011% | ||
| 02/09/26 | Exercice | Director | 1,200 | 0.0012% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.12% | +1.64% | +25.12% | +5.30% | 8.15TCr | |
| +0.89% | +1.97% | +58.00% | +129.06% | 1,14300Cr | |
| +0.97% | +5.47% | +45.45% | +84.92% | 65TCr | |
| +0.44% | +1.16% | +26.61% | +103.04% | 51TCr | |
| -0.24% | +1.96% | +53.08% | +65.64% | 38TCr | |
| -0.58% | -5.71% | +62.38% | +37.63% | 35TCr | |
| +0.54% | +2.52% | +31.57% | +53.70% | 29TCr | |
| +0.02% | +2.06% | +3.77% | +25.99% | 26TCr | |
| +0.99% | +3.50% | +55.33% | +72.38% | 24TCr | |
| +0.51% | +4.34% | +35.93% | +106.04% | 20TCr | |
| Average | +0.40% | +0.87% | +39.72% | +68.37% | 41.09TCr | |
| Weighted average by Cap. | +0.54% | +0.71% | +44.82% | +86.27% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.76TCr 1.58TCr 1.46TCr 1.32TCr 2.47TCr 1,67200Cr 2.5TCr 17TCr 6.94TCr 88TCr 6.61TCr 6.47TCr 2,77900Cr | 1.86TCr 1.67TCr 1.54TCr 1.4TCr 2.61TCr 1,76600Cr 2.64TCr 18TCr 7.34TCr 93TCr 6.98TCr 6.83TCr 2,93500Cr |
| Net income | 539.16Cr 483.89Cr 446.81Cr 405.17Cr 757.27Cr 51TCr 766.57Cr 5.36TCr 2.13TCr 27TCr 2.02TCr 1.98TCr 85TCr | 564.11Cr 506.29Cr 467.48Cr 423.92Cr 792.31Cr 54TCr 802.05Cr 5.6TCr 2.23TCr 28TCr 2.12TCr 2.07TCr 89TCr |
| Net Debt | -760.32Cr -682.38Cr -630.08Cr -571.37Cr -1.07TCr -72TCr -1.08TCr -7.55TCr -3TCr -38TCr -2.85TCr -2.79TCr -1,20000Cr | -1.1TCr -984.38Cr -908.93Cr -824.24Cr -1.54TCr -1,04200Cr -1.56TCr -11TCr -4.33TCr -55TCr -4.12TCr -4.03TCr -1,73200Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/26/28 | $818.88 | +0.34% | 1,39,101 |
| 27/26/27 | $816.10 | +1.04% | 7,26,151 |
| 26/26/26 | $807.67 | +0.33% | 4,23,958 |
| 23/26/23 | $805.02 | -1.72% | 5,27,739 |
| 22/26/22 | $819.09 | +1.67% | 8,52,594 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
